Swedish Orphan Biovitrum AB (FRA:B6E)
€ 24.42 -0.08 (-0.33%) Market Cap: 8.36 Bil Enterprise Value: 10.02 Bil PE Ratio: 42.61 PB Ratio: 2.56 GF Score: 88/100

Q4 2020 Swedish Orphan Biovitrum AB (publ) Earnings Call Transcript

Feb 18, 2021 / 12:00PM GMT
Release Date Price: €13.94 (-9.97%)
Operator

Ladies and gentlemen, welcome to the Sobi presentation. (Operator Instructions)

I will now hand over to Guido Oelkers, CEO. Please go ahead.

Guido Oelkers;publ;CEO;President
Swedish Orphan Biovitrum AB

()-&

Yes. Thank you so much, and welcome to the Q4 webcast of Sobi. As per usual, I go straight to the forward-looking statement, and we just take note of it, not going to read it through, but just be aware. Today, I'm going to be joined by my colleagues, Henrik Stenqvist, the CFO; and Ravi Rao, the Head of R&D.

And with this, let's go to the meet of the presentation on Slide 4. And basically, when you look at it, we had -- we have expanded our opportunity horizon for Sobi. I think it's fair to say that we are, this year -- that we have in 2020, but also in 2021, we are in a transition mode, and we are transitioning Sobi to a new reality.

And during this transition, we are experiencing headwinds, foremost COVID, and we will talk about this more in the context of the guidance for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot